-Volume 33 | May 7, 2025
Just seven weeks to go until FACTOR 2025, June 26–28 in Salt Lake City! We’re excited to unite scientists, clinicians, patients, and families, and we can’t wait to see you there! There’s still time to register, book your hotel by May 30, and order luminarias to honor the OsteoWarriors and OsteoAngels who light the way and inspire our collective efforts. This May, we’re filled with gratitude for your incredible support during our Day of Giving, for the extraordinary contributions of Dr. Pete Anderson as he approaches retirement, and for the patients and researchers advancing clinical trials together.
With hope,
The MIB Agents Team
FACTOR only comes once a year and we are less than 2 months out!
Don't miss it! Register today! Book your hotel room by May 30th to guarantee a spot.
We celebrate the legacy of Dr. Pete Anderson, a physician-scientist who has shaped osteosarcoma care and research through decades of clinical excellence, groundbreaking science, and heartfelt advocacy. From lab discoveries to telemedicine, clinical trials to mentorship, Dr. Anderson leaves behind not only a remarkable body of work but also a lasting influence on patients, colleagues, and the field at large. We honor the indelible mark he’s made on pediatric cancer care and research and the osteosarcoma community.
- Pediatric Hem/Onc Faculty Position – Sarcoma - Cleveland Clinic
- Pediatric Oncologist and Medical Director - U of Utah
- Pediatric Hem/Onc - Pediatric Solid Tumor/Sarcoma Program - U of Utah
- Assistant Professor, Tenure Track, Pediatric Sarcoma Research - UPenn
- Clinical Investigator - Sarcoma - Emory University
- Pediatric Solid Tumor Physician - Emory University
If you have a job posting and you would like it included here, please email christina@mibagents.org.
In a time of shrinking scientific funding, legislative advocacy matters more than ever. In this episode of OsteoBites, Nancy Goodman, JD, of Kids v Cancer, explains how policies like the Give Kids a Chance Act can drive pediatric cancer research forward. Learn how smart legislation expands access to cutting-edge therapies—and how you can help advocate for change. Take 2 minutes to send a message to Congress in support of the GKAC Act.
Learn More About the Give Kids a Chance Act
- Cardamom synergizes with cisplatin against human osteosarcoma cells by mTOR-mediated autophagy
Light the path with love. At FACTOR 2025, Luminarias will honor OsteoWarriors and OsteoAngels, beautifully displayed along the route attendees will take to Friday night’s dinner. Each one is a tribute filled with meaning, celebration, and hope.
In honor of Clinical Trials Day on May 20th, we highlight ONTEX, the Osteosarcoma Now Clinical Trial Explorer that summarizes osteosarcoma trials around the world and explains them in accessible language. See NCI-supported osteosarcoma clinical trials and learn about the types and phases of trials and how they are carried out. Check out the OsteoBites Clinical Trials playlist for overviews from the PIs about key osteosarcoma clinical trials. We are grateful 365 days a year for the dedication of clinical research professionals who move innovative therapies from scientific discovery to patients in the clinic.
